The sigma‐1 receptor‐TAMM41 axis modulates neuroinflammation and attenuates memory impairment during the latent period of epileptogenesis
Animal Models and Experimental Medicine · 2025
DOI: 10.1002/ame2.12341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2025. Verfasst von Jianlun Ji und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. Hauptthemen laut MEDLINE: Receptors, sigma, Memory Disorders, Neuroinflammatory Diseases, Epilepsy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Qing Lan Project of Jiangsu Province, Science and Technology Planning Project of Xuzhou.
Abstract (Originalsprache)
Background
Therapy in the latent period is favorable for retarding the process of epileptogenesis. Recently, we have discovered that the activated sigma‐1 receptor (Sig‐1R) attenuates the hippocampus pathological injury and memory impairment in the latent period of epileptogenesis. But the molecular mechanism needs further investigation.
Methods
PRE‐084 was utilized as a research tool to highly selectively activate Sig‐1R in epileptic mice. After the treatment of PRE‐084, the pro‐inflammatory cytokines, neuropathological traits, and the level of mitochondrial translocator assembly and maintenance 41 homolog (TAMM41) in the hippocampus were examined. The mode in which the Sig‐1R interacts with TAMM41 was explored. The role of TAMM41 in the protecting effect of PRE‐084 was established.
Results
PRE‐084 inhibited the growth of pro‐inflammatory cytokines, reduced the formation of gliosis, alleviated neuronal damage in the hippocampus, and attenuated memory impairment in the latent period of epileptogenesis. The protein level of TAMM41 decreased in the hippocampi of epileptic mice and increased in the PRE‐084‐treated mice. The Sig‐1R bound with TAMM41 directly, maintaining the stability of TAMM41. Knockdown of TAMM41 reversed the protective effect of PRE‐084, and overexpression of TAMM41 exhibited a similar protective action to that of PRE‐084.
Conclusion
We presented the concept of the “sigma‐1 receptor–TAMM41 axis” and proposed that augmenting this axis can attenuate neuroinflammation and memory impairment in the process of epileptogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.
- Agro-Products Processing Research Institute, Yunnan Academy of Agricultural Sciences, Kunming, China.
Förderung
- National Natural Science Foundation of China
- Qing Lan Project of Jiangsu Province
- Science and Technology Planning Project of Xuzhou
- The Science and Technology Developing Fund of The Affiliated Hospital of Xuzhou Medical University
Zitieren
APA
Ji, J., Gao, C., Wang, Q., Jia, X., Tian, H., Wei, Y., Liu, Z., Wang, Y., & Guo, L. (2025). The sigma‐1 receptor‐TAMM41 axis modulates neuroinflammation and attenuates memory impairment during the latent period of epileptogenesis. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.12341
Vancouver
Ji J, Gao C, Wang Q, Jia X, Tian H, Wei Y, et al. The sigma‐1 receptor‐TAMM41 axis modulates neuroinflammation and attenuates memory impairment during the latent period of epileptogenesis. Animal Models and Experimental Medicine. 2025. doi:10.1002/ame2.12341
BibTeX
@article{Ji2025,
author = {Ji, Jianlun and Gao, Ce and Wang, Qinghua and Jia, Xiaoxia and Tian, Hao and Wei, Yaqin and Liu, Zhidong and Wang, Yun and Guo, Lin},
title = {The sigma‐1 receptor‐TAMM41 axis modulates neuroinflammation and attenuates memory impairment during the latent period of epileptogenesis},
journal = {Animal Models and Experimental Medicine},
year = {2025},
doi = {10.1002/ame2.12341}
}
EUVIMED